KIZOO Technology Capital Overview
Kizoo Technology Capital provides seed and early-stage financing, focusing on rejuvenation biotechnology aimed at reversing age-related cellular and molecular damage. The firm also offers mentoring to startups in this emerging field.
Is KIZOO Technology Capital the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with KIZOO Technology Capital, along with a list of other relevant VCs, is available on Hopohopo.io.
KIZOO Technology Capital
Investment focus
Product type
- Drugs / Pharma
Industries / verticals
- BioTech & Life Sciences
Investment role
Lead and follow
Stages
Seed, Series A, Series B or later
First ticket size
€250,000 - €5,000,000
Contact information
Managing Director
Frank Schueler
How to approach funds like KIZOO Technology Capital
When reaching out to Kizoo Technology Capital, founders should highlight breakthrough science with clear translational potential and a credible path to clinical or commercial milestones. Demonstrate a strong, mission-driven team with deep technical expertise and a commitment to tackling the core challenges of aging. Articulate how your approach stands out within the rejuvenation biotech landscape, and be prepared to discuss both scientific rigor and long-term impact.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
